Fri.Jun 14, 2024

article thumbnail

Opinion: Certificate of need laws con rural patients out of health care

STAT

News watchers around the U.S. have likely seen the warnings: without certificate of need (CON) laws, hospitals will be forced to close their doors when for-profit organizations open and cherry pick commercially insured patients, leaving those in rural areas without care. The reality is that even with certificate of need laws in place, rural patients are already without care.

Hospitals 359
article thumbnail

Francis Crick, UCL and AZ identify why treatment fails for NSCLC patients

Pharma Times

NSCLC accounts for around 85% of all lung cancer cases, particularly in non-smoking patients

153
153
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Biden administration to recalculate Medicare Advantage quality ratings and bonuses

STAT

The federal government is rescoring the quality ratings of this year’s Medicare Advantage plans, which could lead to an additional $1 billion of taxpayer money flowing into the coffers of health insurance companies. Recent court decisions required the Biden administration to make these changes to insurers’ star ratings, many of which came in lower than companies had expected and cost them hundreds of millions of dollars in bonuses.

article thumbnail

Pfizer’s Paxlovid flunks long COVID study as researchers uncover the condition’s deep toll

PharmaVoice

While researchers gain ground understanding long COVID’s impact, viable treatments could still be a long way off.

147
147
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Opinion: Telling new stories can help people see the value of vaccines

STAT

Nearly nine in 10 Americans strongly believe in the overall value of childhood vaccines. Reflecting the value communities place on them, every state and the District of Columbia require children to get vaccinated against certain diseases before they start school, including measles, mumps, polio, tetanus, whooping cough, and chickenpox. Troubling stories about outbreaks of previously eradicated diseases like measles notwithstanding, most schools are free of vaccine-preventable diseases.

Vaccines 339

More Trending

article thumbnail

Novo Nordisk CEO agrees to Bernie Sanders’ demand to testify on Ozempic, Wegovy prices

STAT

WASHINGTON — Novo Nordisk CEO Lars Fruergaard Jørgensen will testify before the Senate after Sen. Bernie Sanders threatened to subpoena the company over its pricing of the popular diabetes drug Ozempic and the obesity drug Wegovy, the Senate health committee announced Friday. The agreement is a finale to a farcical public back-and-forth over apparent difficulties between the Senate health committee and Novo in scheduling a hearing.

Diabetes 320
article thumbnail

CCA pharmacies have delivered over 200,000 Pharmacy First consultations

The Pharmacist

Large multiple pharmacies have delivered around 200,000 Pharmacy First consultations in under six months. Since 31 January, Company Chemists’ Association (CCA) member pharmacies have delivered 209,200 Pharmacy First consultations, the CCA said on Wednesday. CCA chief executive Malcolm Harrison said the strong patient interest demonstrated ‘that the service is here to stay’.

122
122
article thumbnail

Walgreens executive says it is ‘doubling down’ on recruiting customers into clinical trials

STAT

LOS ANGELES – For the past two years, Walgreens has tried to leverage its nationwide footprint to recruit customers who pick up drugs at its stores into clinical trials , in an effort to diversify participation in studies of new medicines. Other retailers have struggled with similar efforts to expand beyond their core pharmacy operations. Last year, CVS ended its clinical trial endeavors after two years, and earlier this year, Walmart closed several of its medical clinics.

288
288
article thumbnail

10th to 14th June – This week in clinical trials

pharmaphorum

Stay up-to-date with the latest news in clinical trials with highlights from NMD Pharma, Minoryx Therapeutics, Moonlake Immunotherapeutics, and Ipsen. Discover the groundbreaking developments from 10th to 14th June.

115
115
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: Colorado board decides a pricey Novartis medicine is unaffordable

STAT

A blockbuster arthritis drug from Novartis may face a limit on what Colorado health plans pay for the medicine after a state board determined the injectable treatment is “unaffordable” for patients. The Colorado Prescription Drug Affordability Board voted Friday to grant the designation to Cosentyx, which is used to treat conditions such as plaque psoriasis and psoriatic arthritis.

article thumbnail

Radiopharma firm Telix abandons Nasdaq listing plans

pharmaphorum

Radiopharma firm Telix abandons Nasdaq listing plans Phil.

111
111
article thumbnail

STAT+: Up and down the ladder: The latest comings and goings

STAT

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

264
264
article thumbnail

Lupin announces closure of US FDA inspection

Express Pharma

Lupin announced that the United States Food and Drug Administration has completed an inspection of its injectable facility in Nagpur, India. The inspection of the facility was carried out from June 10 to June 13, 2024 , and concluded with zero 483 observations. Nilesh Gupta, Managing Director, Lupin said, “We are pleased to have a successful outcome of the U.S.

110
110
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

DeepWell gamifies breathing therapy for mental health

pharmaphorum

DeepWell gamifies breathing therapy for mental health Phil.

110
110
article thumbnail

Greening India’s industrial horizon: Navigating climate resilience in pharma and beyond

Express Pharma

India’s pharmaceutical industry is a global powerhouse. It is already a massive $50 billion market and is projected to grow to $130 billion by 2030. India makes 60 per cent of the world’s vaccines and 20 per cent of the world’s generic drugs. This shining star does however have two chinks in the armour that industry leaders will be well served to address.

article thumbnail

NHSE medical director 'alarmed' by reports of inappropriate weight loss drug use

The Pharmacist

The national medical director at NHS England has expressed alarm at reports of weight loss medication being used inappropriately. Speaking at the NHS Confed Expo conference in Manchester this week, Professor Stephen Powis said that new weight loss drugs were going to be an ‘important part’ of the NHS’s approach to tackling obesity. But he […] The post NHSE medical director 'alarmed' by reports of inappropriate weight loss drug use appeared first on The Pharmacist.

108
108
article thumbnail

Takeda signs option agreement with Ascentage for CML drug

Pharmaceutical Technology

If exercised, the option would allow Takeda to license the TKI olverembatinib outside China, Hong Kong, Macau, Taiwan and Russia.

105
105
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

SKAN research trust, Quadram Institute Bioscience to develop novel microbial therapies

Express Pharma

SKAN Research Trust, promoted by Indian entrepreneur Ashok Soota, and UK-based Quadram Institute Bioscience announced that they will apply the TraDIS-Xpress platform to study the action of traditional medical compounds on bacteria, thereby aiding in the reformulation and development of novel antibacterial regimens. TraDIS-Xpress is Quadram’s proprietary genetic sequencing platform that is working to uncover new antimicrobial agents and develop better prebiotics and probiotics for health promotio

article thumbnail

AbbVie and FutureGen link on inflammatory bowel disease

Pharmaceutical Technology

AbbVie has made a licence agreement with FutureGen Biopharmaceutical for developing FG-M701 for inflammatory bowel disease (IBD).

105
105
article thumbnail

Data shows durability of pain relief for patients with knee osteoarthritis (OA)

Express Pharma

Sun Pharmaceutical Industries, (including its subsidiaries or associate companies) and Israel-based Moebius Medical presented data demonstrating the durability of pain relief achieved in symptomatic knee OA patients through 26 weeks post-injection of MM-II. The results, presented at EULAR 2024, are based on an analysis from the randomised, controlled, Phase 2b clinical study (NCT04506463).

101
101
article thumbnail

Pre-diabetes rates increase amidst a renaissance for type 2 diabetes research

Pharmaceutical Technology

England’s NHS has reported an 18% increase in the number of people with non-diabetic hyperglycaemia, also known as pre-diabetes.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

AbbVie to advance TL1A antibody for IBD

European Pharmaceutical Review

AbbVie and FutureGen Biopharmaceutical (Beijing) Co., Ltd. have made a license agreement, whereby AbbVie will develop, manufacture and commercialise a next generation TL1A antibody for inflammatory bowel disease (IBD). FG-M701 is a fully human monoclonal antibody targeting TL1A. This target plays a role in inflammatory autoimmune diseases. While AbbVie is set to advance the monoclonal antibody through development and beyond, the treatment is currently in preclinical development.

98
article thumbnail

Adult flu campaign to start 3 October but QIVr vaccine unavailable

The Pharmacist

Pharmacies have been advised they should order alternative vaccines from an approved list, after Sanofi has said its recombinant quadrivalent influenza vaccine (QIVr) would not be available for this year’s flu programme. In addition, the start date for the 2024/25 adult flu vaccination campaign has been confirmed as 3 October, NHS England announced in this […] The post Adult flu campaign to start 3 October but QIVr vaccine unavailable appeared first on The Pharmacist.

article thumbnail

Obesity-cancer connection discovery suggests strategies for improving immunotherapy

World Pharma News

Immune system cells called macrophages play an unexpected role in the complicated connection between obesity and cancer, a Vanderbilt University Medical Center-led research team has discovered. Obesity increases the frequency of macrophages in tumors and induces their expression of the immune checkpoint protein PD-1 - a target of cancer immunotherapies.

article thumbnail

FDA widens label for BMS’ cancer drug Augtyro

pharmaphorum

FDA widens label for BMS’ cancer drug Augtyro Phil.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.